Source: The CQC/NHS England
Extended government restrictions on use of puberty suppressing hormones (puberty blockers):
information for prescribers and pharmacists / dispensing doctors.
Since 3 June 2024, in Great Britain, temporary emergency restrictions have been in place
preventing the use of gonadotrophin releasing hormone (GnRH) analogues used to suppress
puberty as part of treatment for gender incongruence or gender dysphoria in children and
young people under 18 years of age.
The government has now passed further legislation to maintain the restrictions in Great
Britain and extend them to Northern Ireland for the first time. The restrictions will come into
effect in Northern Ireland on 27 August 2024 and expire across the UK at the end of 26
November 2024.
The government launched a consultation and engagement exercise, in August 2024, to
inform a decision as to whether to make the restrictions permanent.
Click here to read in full.
